Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Bacteriophages for Ventilator-Associated Pneumonia Due to Pseudomonas Aeruginosa
NCT07804082Phase 3Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2026
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
A Phase 3 trial of bacteriophages in ventilator-associated pneumonia (VAP), sponsored by Assistance publique - Hôpitaux de Paris. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
bacteriophages
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT07804082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07804082.